Skip to main content
HeartCited

NMN (Nicotinamide Mononucleotide) para Arterial Stiffness

C

Single RCT showed improved pulse wave velocity in middle-aged adults. NAD+ restoration mechanism is compelling. Larger cardiovascular-specific trials are ongoing.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dnmn\u0026condition\u003Darterial\u002Dstiffness'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

Conclusão

Single RCT showed improved pulse wave velocity in middle-aged adults. NAD+ restoration mechanism is compelling. Larger cardiovascular-specific trials are ongoing.

Key Statistics

2

Estudos

100

Participantes

Positive

C

Nota

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosagens Comumente Utilizadas

general:
250-500 mg/day
antiagingprotocols:
500-1,000 mg/day

Limite superior: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e

Melhor horário: Morning on empty stomach or with light meal; sublingual for enhanced bioavailability

Safety & Side Effects

Efeitos Colaterais Relatados

  • Generally well-tolerated
  • Mild gastrointestinal discomfort
  • Flushing (rare)
  • Headache (rare)

Interações Conhecidas

  • May interact with NAD+-dependent medications
  • Theoretical interaction with diabetes medications (may affect glucose metabolism)

Ingestão máxima tolerável: Not formally established; up to 1,200 mg/day used in human trials without significant adverse e

Consulte sempre o seu profissional de saúde antes de iniciar qualquer suplemento.Sempre consulte seu profissional de saúde antes de iniciar qualquer suplemento.

Frequently Asked Questions

Does NMN (Nicotinamide Mononucleotide) help with Arterial Stiffness?
Based on 2 studies with 100 participants, there is limited but promising evidence that NMN (Nicotinamide Mononucleotide) may support Arterial Stiffness management. Our evidence grade is C (Some Evidence).
How much NMN (Nicotinamide Mononucleotide) should I take for Arterial Stiffness?
Studies have used various dosages. A commonly studied range is 250-500 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of NMN (Nicotinamide Mononucleotide)?
Reported side effects may include Generally well-tolerated, Mild gastrointestinal discomfort, Flushing (rare), Headache (rare). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for NMN (Nicotinamide Mononucleotide) and Arterial Stiffness?
We rate the evidence as Grade C (Some Evidence). This rating is based on 2 peer-reviewed studies with 100 total participants. The overall direction of effect is positive.

Related Evidence

Outros ingredientes para Arterial Stiffness

NMN (Nicotinamide Mononucleotide) para outras condições

Aviso Legal da FDA: Estas declarações não foram avaliadas pela Food and Drug Administration. Os produtos e informações neste site não se destinam a diagnosticar, tratar, curar ou prevenir qualquer doença. As notas de evidência apresentadas são baseadas em nossa análise de pesquisas revisadas por pares publicadas e não constituem aconselhamento médico. Sempre consulte seu profissional de saúde antes de iniciar qualquer regime de suplementação.